Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00501_DB06684_nanopub.RA4gE_D48gMAW2smvRGxzl3TwPUtzRljRPyi_4ikSEi00#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00501_DB06684 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00501_DB06684 label "DDI between Cimetidine and Vilazodone - Cimetidine may decrease the metabolism of Selective Serotonin Reuptake Inhibitors. Consider using an alternative H2-antagonist to avoid the risk of selective serotonin reuptake inhibitor (SSRI) toxicity. Monitor for increased therapeutic or toxic effects of SSRI if cimetidine is initiated/dose increased, or decreased effects if cimetidine is discontinued/dose decreased. [drugbank_resource:DB00501_DB06684]" assertion.
- drugbank_resource:DB00501_DB06684 identifier "drugbank_resource:DB00501_DB06684" assertion.
- drugbank_resource:DB00501_DB06684 title "DDI between Cimetidine and Vilazodone - Cimetidine may decrease the metabolism of Selective Serotonin Reuptake Inhibitors. Consider using an alternative H2-antagonist to avoid the risk of selective serotonin reuptake inhibitor (SSRI) toxicity. Monitor for increased therapeutic or toxic effects of SSRI if cimetidine is initiated/dose increased, or decreased effects if cimetidine is discontinued/dose decreased." assertion.
- drugbank:DB00501 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00501_DB06684 assertion.
- drugbank:DB06684 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00501_DB06684 assertion.